Skip to nav Skip to content

Disorders

IL-10 Receptor Defects

  • Inheritance: Autosomal recessive
  • Genes: IL-10RA and IL-10RB
  • Proteins: IL-10RA and IL-10RB
  • Tests: IL-10 Receptor Gene Sequencing (IL10RA/IL10RB), IL-10 Receptor Function Screen by Flow  

Key Clinical and Laboratory Features

  • Common clinical features: Severe, early-onset, fistulating inflammatory colitis that is often resistant to therapy. Follicular dermatitis/folliculitis.
  • Other clinical features: Lymphoma (typically B cell), gingivitis
  • Physical exam: Severe inflammatory colitis observed by endoscopy. Proctitis is common.
  • Common laboratory features: Elevated inflammatory markers, leukocytosis

Testing Approach

 TESTCOMMENTS
GENE IL-10 Receptor Gene Sequencing (IL10RA/IL10RB) The gold standard for confirming a diagnosis of IL-10 receptor deficiency in patients with an abnormal IL-10 Receptor Function Screen.
PROTEIN N/A There are currently no available clinical tests to evaluate IL-10RA or IL-10RB protein expression on patient cells.
FUNCTION IL-10 Receptor Function Screen by Flow   This functional test evaluates the ability of IL-10 to induce tyrosine phosphorylation of STAT3 in patient cells. If the IL-10 receptors are absent or non-functional, no STAT3 phosphorylation is observed. This test is estimated to be at least 90% sensitive to detect patients with defects in one or the other of the IL-10 receptor chains. This test will not identify patients who have IL-10 deficiency.
OTHER   Complete blood count with differential: Leukocytosis can be present.
 

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.